新聞稿 | HIPRA

who we are

新聞稿

11/04/2024 - 10:02

Clone of Significant advancements and a fifteen-month extension for the RBDCOV Project

人類

06/26/2024 - 15:09

Significant advancements and a fifteen-month extension for the RBDCOV Project

人類

10/18/2023 - 16:14

BIMERVAX® becomes the first COVID-19 vaccine approved by WHO

人類

07/17/2023 - 14:43

AEMPS authorizes the clinical trial to study the joint vaccination of HIPRA's COVID-19 vaccine with an influenza vaccine

人類

05/29/2023 - 08:15

AEMPS authorizes the clinical trial to study HIPRA's COVID-19 vaccine in adolescents between 12 and 17 years old

人類

04/11/2023 - 16:57

The Spanish Prime Minister defines HIPRA’s vaccine as a 'historic milestone' that reinforces the country's leadership in the European health sector

人類